Whole-brain modelling supports the use of serotonergic psychedelics for the treatment of disorders of consciousness
bioRxiv Preprint Server December 29, 2023 Iván Mindlin, Rubén Herzog, Laouen Belloli et al. 7 citations preprint
Disorders of consciousness (DoC) are a challenging and complex group of neurological conditions characterised by absent or impaired awareness. The current range of therapeutic options for DoC patients is limited, offering few non-invasive pharmacological alternatives. This situation has sprung a growing interest in the development of novel treatments, such as the proposal to study the efficacy...